Drug intelligence / Profile preview

Immunorell

Development stage: Unknown
Lead developer: Sanorell Pharma
Administration: Intradermal, Intramuscular, Intravenous, Oral, Subcutaneous

Overview

**Immunorell** is a Sanorell Pharma registered homeopathic medicinal product for adults, marketed in Germany as both oral drops and an injectable solution. It contains homeopathic dilutions of *Eupatorium perfoliatum*, *Echinacea*, ferrum phosphoricum, and hepar sulfuris. Official product information states that it is registered without a therapeutic indication; no evidence-based molecular target or pharmacological mechanism is specified. ([sanorell.de](https://sanorell.de/produkt/immunorell-tropfen/))

Brand names: Immunorell

Beyond the preview

Go deeper on Immunorell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunorell.

Explore the full profile